Spero Therapeutics, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2025
Total Assets: $68.9M
Liabilities Breakdown FY2025
Total Liabilities: $9.9M
Asset Breakdown
Total Assets: $68.9M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $40.3M | 58.4% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $0 | 0.0% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $28.7M | 41.6% |
Liabilities Breakdown
Total Liabilities: $9.9M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $693.0K | 7.0% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $9.2M | 93.0% |